Company: HCTI
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001213900-25-021346
Chunk: 14

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 14
---
 direction and intellectual property as more fully discussed under “Risk Factors” in our Annual Report on Form 10 -K. Management is responsible for the day -to -daymanagement of risks we face, while our Board of Directors, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our Board of Directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. Risks Related to Compensation Policies and Practices In establishing and reviewing our compensation philosophy and programs, we consider whether such programs encourage unnecessary or excessive risk taking. We believe that our executive compensation program does not encourage excessive or unnecessary risk taking. This is primarily due to the fact that our compensation programs are designed to encourage our executive officers and other employees to remain focused on both short- term and long -termstrategic goals. As a result, we do not believe that our compensation programs are reasonably likely to have a material adverse effect on us. Board Committees Our Board of Directors has established three standing committees: audit, leadership and compensation, and nominating and corporate governance. We have appointed persons to the Board of Directors and committees of the Board of Directors as required to meet the corporate governance requirements of the Nasdaq. The audit committee, compensation committee and nominating and corporate governance committee all operate under charters approved by our Board of Directors (copies of which can be found on our website by visiting h ttps://www.healthcaretriangle.com/investors/governence/polici es.During the fiscal year ended December 31, 2024, the audit committee met 4 times, the compensation committee met 1 times, and the nominating and corporate governance committee met 1 times. During their respective terms of service, each director attended at least 75% of all meetings of the committees on which they then served, which were held during 2024. Our Board of Directors may from time to time establish other committees. Board and Committee Evaluations The nominating and corporate governance committee intends to establish the Board and committee evaluation process and may determine to use an independent third -partyevaluation process from time to time in the future. No board or committee evaluations were undertaken in 2024. Director Attendance at Annual Meeting of Stockholders Directors are encouraged to attend the annual meeting of stockholders to the extent practicable. We held an annual meeting of stockholders in 2023 as we were a public company. Audit Committee We have a separately designated standing audit committee of our